Transcranial Magnetic Stimulation Reduces Dyskinesias in Parkinson's Disease
Author Information
Author(s): Ramírez-López Fernanda, García-Montes José Rubén, Millán-Aldaco Diana, Palomero-Rivero Marcela, Túnez-Fiñana Isaac, Drucker-Colín René, Roldán-Roldán Gabriel, Johri Ashu
Primary Institution: Universidad Nacional Autónoma de México
Hypothesis
Does transcranial magnetic stimulation (TMS) affect dyskinetic behavior and the expression of FosB and c-Fos in a Parkinson's disease model?
Conclusion
TMS reduces dyskinesias and decreases the expression of FosB and c-Fos in specific brain regions associated with motor control.
Supporting Evidence
- TMS significantly decreased dyskinesias after 21 days of treatment.
- FosB expression was significantly reduced in the striatum of TMS-treated rats.
- Motor performance improved in the beam test after TMS treatment.
- TMS halted c-Fos expression in D1R-containing cells.
- Withdrawal of TMS led to an increase in dyskinesias and FosB expression.
Takeaway
This study shows that a special type of brain stimulation can help reduce unwanted movements in rats with Parkinson's disease.
Methodology
The study used male Wistar rats, assessing the effects of TMS on dyskinetic behavior and measuring cellular activation through immunohistochemistry.
Potential Biases
Potential variability in TMS protocols and differences in animal models may introduce bias.
Limitations
The study did not explore the effects of TMS on other brain regions involved in dyskinesias.
Participant Demographics
142 male Wistar rats aged 230-250 g.
Statistical Information
P-Value
p<0.01
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website